Phosphoric Acid

Phosphoric Acid

SCHEMBL377386

COc1ccc2c(Oc3ccc(NC(=O)c4c(C)n(C[C@@H](C)OC(=O)[C@H](C)N)n(-c5ccccc5)c4=O)nc3)ccnc2c1.O=P(O)(O)O

nearest known ligand 0.80

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

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

The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR known ✓ P35968 19/20 0.80
JAK2 known ✓ O60674 1/20 0.71
KIT known ✓ P10721 1/20 0.71
FGFR1 known ✓ P11362 1/20 0.71
JAK1 known ✓ P23458 1/20 0.71
JAK3 known ✓ P52333 1/20 0.71
IGF1R P08069 20/20 0.80
MET P08581 20/20 0.80
AURKA O14965 1/20 0.71
RPS6KA5 O75582 1/20 0.71
ABL1 P00519 1/20 0.71
INSR P06213 1/20 0.71
LCK P06239 1/20 0.71
FES P07332 1/20 0.71
CSF1R P07333 1/20 0.71
LYN P07948 1/20 0.71
RET P07949 1/20 0.71
FGR P09769 1/20 0.71
PIM1 P11309 1/20 0.71
SRC P12931 1/20 0.71

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL373798 0.98 IGF1R (0.82) IGF1RMETKDRAURKAJAK2
SCHEMBL11911661 0.98 IGF1R (0.82) IGF1RMETKDRAURKAJAK2
SCHEMBL3674699 0.98 IGF1R (0.82) IGF1RMETKDRAURKAJAK2
Hydrochloric Acid SCHEMBL3676223 0.97 IGF1R (0.81) IGF1RMETKDRAURKAJAK2
Hydrochloric Acid SCHEMBL374240 0.97 IGF1R (0.81) IGF1RMETKDRAURKAJAK2
Hydrochloric Acid SCHEMBL374042 0.97 IGF1R (0.81) IGF1RMETKDRAURKAJAK2
Oxalic Acid SCHEMBL377624 0.97 IGF1R (0.81) IGF1RMETKDRAURKAJAK2
Acetic Acid SCHEMBL3674561 0.97 IGF1R (0.81) IGF1RMETKDRAURKAJAK2
Oxalic Acid SCHEMBL377625 0.97 IGF1R (0.81) IGF1RMETKDRAURKAJAK2
Acetic Acid SCHEMBL374114 0.97 IGF1R (0.81) IGF1RMETKDRAURKAJAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2408300-B1 AMINO ESTER DERIVATIVES, SALTS THEREOF AND METHODS OF USE SUNSHINE LAKE PHARMA CO LTD (CN) 2016-05-11 EP disclosed
EP-2408300-A1 AMINO ESTER DERIVATIVES, SALTS THEREOF AND METHODS OF USE Sunshine Lake Pharma Co., Ltd (CN) 2012-01-25 EP disclosed
WO-2010111063-A1 AMINO ESTER DERIVATIVES, SALTS THEREOF AND METHODS OF USE XI NING (US) 2010-09-30 WO disclosed